Tjerk H Geersing

OLVG, Leiden University

Papers

6

Total Citations

90

H-Index

5

About

Tjerk H. Geersing is a leading researcher in the field of pharmaceutical compounding, with a focus on the safety, accuracy, and efficiency of preparing hazardous drugs. His work primarily explores the transition from manual to robotic compounding systems, addressing critical issues such as environmental contamination, dosing precision, and operational costs. Geersing’s major contributions include demonstrating that robotic systems like APOTECAchemo significantly reduce external cross-contamination of cytotoxic drugs compared to manual methods, as shown in his highly cited 2019 study (25 citations). He has also validated the microbiological safety of robotic compounding (23 citations) and proven its superior dosing accuracy (17 citations). Beyond safety, Geersing has advanced economic efficiency through vial-sharing strategies for expensive drugs (13 citations) and analyzed production capacity to optimize hospital workflows (7 citations). His recent work on monoclonal antibody stability in infusion bags (5 citations) further underscores his commitment to ensuring drug integrity. With over 90 total citations, Geersing’s research is pivotal for modernizing pharmacy practices, reducing occupational exposure risks, and enhancing patient safety in chemotherapy preparation.

Research Focus

Key Achievements

5
H-Index
6
Papers
90
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs: a comparison between a robotic system and conventional manual production
25 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: OLVG, Leiden University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago